Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released May 15, 2024, during market hours
10-Q filed May 15, 2024, 45 days after period end · 0000950170-24-060401
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $2.15M | $2.32M | $1.89M | $1.50M |
| Net Income | -$4.63M | -$6.58M | -$9.27M | -$5.92M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.39 |
| -$0.79 |
| -$1.24 |
| -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
